D
Definitive Healthcare Corp
NASDAQ:DH
Definitive Healthcare Corp
NASDAQ:DH
Price:
7.03 USD
0.57%
Market Closed
Updated:
May 6, 2024
Definitive Healthcare Corp
Research & Development
|
Definitive Healthcare Corp
Research & Development Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
CERT
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
D
|
Definitive Healthcare Corp
NASDAQ:DH
|
Research & Development
-$42.4m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$116.5m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$80.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Research & Development
-$34.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Definitive Healthcare Corp's Research & Development?
Research & Development
-42.4m
USD
-42.4m
USD
Based on the financial report for Dec 31, 2023, Definitive Healthcare Corp's Research & Development amounts to -42.4m USD.
What is Definitive Healthcare Corp's Research & Development growth rate?
Research & Development CAGR 3Y
-56%
-56%
Over the last year, the Research & Development growth was -22%. The average annual Research & Development growth rates for Definitive Healthcare Corp have been -56% over the past three years .
You don't have any saved screeners yet
